Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CNB Financial Corp
CCNE
$1.03B
| $947K | ﹤0.01% |
52,301
-1,300
| -2% | -$24.1K |
|
2352
Black Diamond Therapeutics
BDTX
$116M
| $944K | ﹤0.01% |
328,900
+108,200
| +49% | +$399K |
|
2353
ProShares Short High Yield
SJB
$47.6M
| $943K | ﹤0.01% |
51,100
-4,100
| -7% | -$75.2K |
|
|
AHT
2354
Ashford Hospitality Trust
AHT
$20.8M
| $941K | ﹤0.01% |
39,390
+7,210
| +22% | +$229K |
|
2355
Lindsay Corp
LNN
$1.17B
| $941K | ﹤0.01% |
8,000
-7,000
| -47% | -$865K |
|
2356
1-800-Flowers.com
FLWS
$262M
| $939K | ﹤0.01% |
134,085
-195,515
| -59% | -$1.47M |
|
2357
iShares Core Conservative Allocation ETF
AOK
$794M
| $937K | ﹤0.01% |
27,600
+4,300
| +18% | +$150K |
|
2358
Northrim BanCorp
NRIM
$606M
| $931K | ﹤0.01% |
94,000
-33,200
| -26% | -$356K |
|
2359
Comtech Telecommunications
CMTL
$52.7M
| $930K | ﹤0.01% |
106,250
+433
| +0.4% | +$4.04K |
|
2360
Adicet Bio
ACET
$78.4M
| $927K | ﹤0.01% |
42,313
+29,163
| +222% | +$1.03M |
|
2361
Mesa Laboratories
MLAB
$593M
| $925K | ﹤0.01% |
8,800
-14,200
| -62% | -$1.82M |
|
2362
Capital Group Growth ETF
CGGR
$25.1B
| $921K | ﹤0.01% |
37,600
+22,400
| +147% | +$569K |
|
2363
Sensus Healthcare
SRTS
$47.1M
| $920K | ﹤0.01% |
332,273
-35,661
| -10% | -$109K |
|
|
LOGC
2364
DELISTED
ContextLogic
LOGC
| $920K | ﹤0.01% |
208,577
-116,900
| -36% | -$728K |
|
2365
MGE Energy Inc
MGEE
$3.09B
| $918K | ﹤0.01% |
13,400
+1,100
| +9% | +$83.4K |
|
2366
Ring Energy
REI
$357M
| $918K | ﹤0.01% |
+470,600
| New | +$943K |
|
2367
Aware
AWRE
$26.4M
| $917K | ﹤0.01% |
664,850
-5,990
| -0.9% | -$9.17K |
|
2368
First Trust Dorsey Wright Focus 5 ETF
FV
$3.82B
| $917K | ﹤0.01% |
20,700
+16,200
| +360% | +$754K |
|
2369
Atossa Therapeutics
ATOS
$25.9M
| $915K | ﹤0.01% |
82,825
+11,220
| +16% | +$163K |
|
2370
Stepan Co
SCL
$1.48B
| $915K | ﹤0.01% |
12,200
-17,700
| -59% | -$1.55M |
|
2371
iShares MSCI World ETF
URTH
$8.39B
| $913K | ﹤0.01% |
7,599
-3,901
| -34% | -$486K |
|
2372
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $912K | ﹤0.01% |
17,099
-13,501
| -44% | -$741K |
|
2373
First United
FUNC
$293M
| $912K | ﹤0.01% |
56,195
-5,420
| -9% | -$87.8K |
|
2374
GigaCloud Technology
GCT
$1.85B
| $912K | ﹤0.01% |
103,500
+67,200
| +185% | +$693K |
|
2375
Mineralys Therapeutics
MLYS
$2.27B
| $910K | ﹤0.01% |
+95,690
| New | +$1.25M |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.